Saba Capital Income & Opportunities Fund (BRW)
NYSE: BRW · Real-Time Price · USD
7.73
0.00 (0.00%)
Dec 20, 2024, 4:00 PM EST - Market closed

Company Description

Saba Capital Income & Opportunities Fund is a closed-ended fixed income mutual fund launched by Voya Investment Management LLC.

The fund is managed by Saba Capital Management, L.P. It invests in the fixed income markets of the United States.

The fund seeks to invest in securities of companies operating across diversified sectors. It primarily invests in floating rate secured senior loans, with an emphasis on top-tier, non-investment grade senior loans.

The fund seeks to invest in loans with maturities of one to ten years. It benchmarks the performance of its portfolio against the S&P/LSTA Leveraged Loan Index.

The fund was formerly known as Voya Prime Rate Trust. Saba Capital Income & Opportunities Fund was formed on December 2, 1987 and is domiciled in the United States.

Saba Capital Income & Opportunities Fund
Saba Capital Income & Opportunities Fund logo
Country United States
Founded 1987
Industry Asset Management
Sector Financials
CEO Stanley David Vyner

Contact Details

Address:
405 Lexington Avenue, 58th Floor
New York, New York 10174
United States
Phone (212) 542-3610
Website investments.voya.com

Stock Details

Ticker Symbol BRW
Exchange NYSE
Reporting Currency USD
CIK Code 0000826020
CUSIP Number 78518H202
ISIN Number US78518H2022
Employer ID 95-6874587

Key Executives

Name Position
Jeffrey Alan Bakalar Portfolio Manager
Stanley David Vyner Chief Investment Risk Officer and Executive Vice President

Latest SEC Filings

Date Type Title
Dec 6, 2024 144 Filing
Oct 29, 2024 SCHEDULE 13G Filing
Sep 27, 2024 NPORT-P Monthly Portfolio Investments Report on Form N-PORT (Public)
Aug 29, 2024 N-PX Annual Report of proxy voting record of management investment companies
Jul 19, 2024 144 Filing
Jul 8, 2024 N-CSRS Filing
Jul 3, 2024 40-17G Filing
Jun 27, 2024 NPORT-P Monthly Portfolio Investments Report on Form N-PORT (Public)
May 21, 2024 DEF 14A Other definitive proxy statements
Apr 16, 2024 144 Filing